Cross-topic event
Observational Study: GLP-1 Drug Users Show ~30% Lower Breast Cancer Risk
Jun 6, 20262 reports
Jun 6, 2026
Sciencedesk view
Observational Study: GLP-1 Drug Users Show ~30% Lower Breast Cancer Risk
Per ScienceDaily, Penn Medicine, ACR, and related coverage from June 2–6, 2026, Elizabeth McDonald's team at the University of Pennsylvania presented at the 202…
READ THE DAY'S DIGEST →
Sports/Healthdesk view
ASCO 2026: GLP-1 Weight-Loss Drugs Linked to ~30% Lower Breast Cancer Risk
Per Euronews on June 4, an observational study presented at the 2026 ASCO Annual Meeting analyzed 110,000+ women aged 45–80: those using GLP-1 receptor agonists…
READ THE DAY'S DIGEST →